References
Beaumont J. L., Lemort N.: Les immunoglobulines anti-héparine. Un facteur de thrombose, d’hyperlipidémies et d’athérosclérose — Path. et Biol.22, 68, 1974.
Bendixen G., Søborg M.: Comments on the leukocyte migration technique as anin vitro method for demonstrating cellular hypersensitivity in man — J. Immunol.104, 1551, 1970.
Collen D., Schetz J., De Cock F., Holmer E., Verstraete M.: Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration — Europ. J. clin. Invest.7, 27, 1977.
Cooper D. A., Petts V., Luckhurst E., Penny R.: The effect of acute and prolonged administration of prednisolone and ACTH on lymphocyte subpopulations — Clin. exp. Immunol.28, 467, 1977.
Essien E. M.: The role of heparin on the inhibition of platelet adhesion to damaged arterial endothelial surface — Thrombos. Diathes. haemorrh. (Stuttg.)34, 600, 1975.
Gatti R. A., Svedmyr E. A. J., Wigzell H.: Characterization of a serum inhibitor of MLC reactions. II. Molecular structure and dissociation of inhibition against responder and stimulator function — Cell. Immunol.11, 466, 1974.
Gerõ S.: Allergy and autoimmune factors. In:Schettler F. G., Boyd G. S. (Eds): Atherosclerosis. Elsevier, Amsterdam, 1969; p. 655.
Gerõ S., Gergely J., Jakab L., Székely J., Virág S., Farkas K., Czuppon A.: Inhibition of cholesterol atherosclerosis by immunisation with β-lipoprotein — Lancetii, 6, 1959.
Gerõ S., Székely J., Szondy É., Seregélyi É.: Immunological studies with aortic and venous tissue antigens. II. Antibodies to vascular antigens — Paroi artér.3, 89, 1975.
Goodnight J. E., Coleman D. A., Steinmüller D.: Serum blocking factors versus specific cellular tolerance in long-term survival of rat heart allografts — Transplantation22, 391, 1976.
Horváth M., Alföldy P., Onody K., Petrányi Gy., Szondy É., Gerõ S.: Immunological studies with aortic and venous tissue antigens. III. Examination of cell-mediated and humoral immune response induced by human vascular antigens — Paroi artér.4, 89, 1978.
Horváth M., Onody K., Gerõ S.: Cell-mediated and humoral immune response in various vascular diseases — Allergol. Immunopath.8, 81, 1980.
Li E. H. H., Fenton J. W. II,Feinman R. D.: The role of heparin in the thrombin-antithrombin III reaction — Arch. Biochem.175, 153, 1976.
Lippman M. M., Methews M. B.: Heparins: varying effects on cell proliferationin vitro and lack of correlation with anticoagulant activity — Fed. Proc.36, 55, 1977.
Olivecrona T., Bengtsson G., Marklund S. E., Lindahl U., Höök M.: Heparin lipoprotein lipase interactions — Fed. Proc.36, 60, 1977.
Petrányi Gy.: A cytostatikus gyógykezelés veszélyei. (Dangers of cytostatic therapy) — Orv. Hetil.119, 63, 1978.
Rao Subba D. S. V., Grogan J. B.: Host response to tissues placed in the anterior chamber of the eye: demonstration of migration inhibition factor and serum blocking activity — Cell. Immunol.33, 125, 1977.
Robert L., Robert M., Moczar M., Moczar E.: Constituents macromoléculaires de la paroi artérielle: antigénicité et rôle dans l’athérosclérose. In: Le rôle de la paroi artérielle dans l’athérogénèse. CNRS, Paris, 1968; p. 395.
Scebat L., Renais J., Iris L., Groult N., Lenégre J.: Lésions artérielles généralisées déclenchées chez le lapin par un traumatisme artériel localisé: rôle possible d’autoanticorps antiaorte. In: Le rôle de la paroi artérielle dans l’athérogénèse. CNRS, Paris, 1968; p. 425.
Schwartz S. I., Kutner F. R., Neistadt A., Barner H., Resnicoff S., Vaughan J.: Antigenicity of homografted veins — Surgery61, 471, 1967.
Stevenson R. D.: Effect of steroid therapy onin vitro polymorph migration — Clin. exp. Immunol.23, 285, 1976.
Szabó G., Szegedi Gy., Fekete B., Petrányi Gy.: A sejtmigratiogátlás módszerének alkalmazása a celluláris tipusú autoimmun válaszkészség vizsgálatára. (The investigation of cellular immune reactivity by leukocyte migration test) — Orv. Hetil.113, 134, 1972.
Szigeti I., Jákó J., Domán J.: Study of the antigenic and immunopathological effects of structural proteins of the mammalian arterial wall and their role in the pathogenesis of atherosclerosis. In: Le rôle de la paroi artérielle dans l’athérogénèse. CNRS, Paris, 1968; p. 493.
Tagucki K., Gordon J., MacLean L. D.: Suppressed cell-mediated immunity due to a serum factor in bacterial sepsis — Surg. Forum25, 33, 1974.
Ting C. C.: Afferent and efferent interference of cell-mediated cytotoxic reactions by heparin — J. nat. Cancer Inst.57, 455, 1976.
Webel M. L., Ritts R. R. Jr.: The effects of corticosteroid concentrations on lymphocyte blastogenesis — Cell. Immunol.32, 287, 1977.
Williams G. M., Haar A., Krajewski C., Parks L. C., Roth J.: Rejection and repair of endothelium in major vessel transplants — Surgery78, 694, 1975.
Williams R. C., Lies R. B., Messner R. R.: Inhibition of mixed leukocyte culture responses by serum and gammaglobulin fractions from certain patients with connective tissue disorders — Arthr. and Rheum.16, 597, 1973.
Zucker M. B.: Heparin and platelet function — Fed. Proc.36, 47, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gerõ, S., Horváth, M. & Szondy, É. The influence of autologous sera and various drugs on the migration inhibition induced by vascular extracts in patients with coronary and peripheral arteriosclerosis. La Ricerca Clin. Lab. 12, 127–135 (1982). https://doi.org/10.1007/BF02909318
Issue Date:
DOI: https://doi.org/10.1007/BF02909318